
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | - | - | - | - | - |
| SPY | - | - | - | - | - |
Historical total returns · Dividends reinvested
No weak spot in its numbers right now.
Loading…
In 1 copy portfolio. See which with Premium
No company summary is available right now.
Suffolk Celebrates Completion of Gilead Sciences Research Center With Ribbon CuttingYahoo Finance · 5 h ago
Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035Yahoo Finance · 6 h ago
Allogeneic Cell Therapy - Global Strategic Business Report 2026: Capitalize on 27.7% CAGR to Capture $2.4B by 2032 with Allogene, Gilead Sciences, Atara and NkartaYahoo Finance · 6 h ago